Recent and select publications
De Silva RA, Jain S, Lears KA, Chong HS, Kang CS, Sun X, Rogers BE: Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development. Nucl Med Biol 39:1099-1104, 2012. PMCID: PMC3470735.
Kang CS, Wu N, Chen Y, Bandara N, Liu D, Lewis MR, Rogers BE, Chong HS: Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation. J Inorg Biochem 154:60-66, 2016. PMCID: PMC4679499.
Kapoor V, Dadey DY, Nguyen K, Wildman SA, Hoye K, Khudanyan A, Bandara N, Rogers BE, Thotala D, Hallahan DE: Tumor specific binding of radiolabeled PEGylated GIRLRG peptide; a novel agent for targeting cancers. J Nucl Med Epub, 2016.
Lears KA, Ferdani R, Liang K, Zheleznyak A, Andrews R, Sherman CD, Achilefu S, Anderson CJ, Rogers BE: In vitro and in vivo evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor-Expressing Prostate Cancer. J Nucl Med 52:470-477, 2011. PMCID: PMC3088991.
Lears KA, Parry JJ, Andrews R, Nguyen K, Wadas TJ, Rogers BE: Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein. Cancer Gene Ther 22:215-221, 2015. PMCID: PMC4409539.
Liu L, Rogers BE, Aladyshkina N, Cheng B, Lokitz SJ, Curiel DT, Mathis JM: Construction and radiolabeling of adenovirus variants that incorporate human metallothionein into protein IX for analysis of biodistribution. Mol Imaging 13:1-12, 2014. PMCID: None.
Richter S, Wuest M, Bergman CN, Way JD, Krieger S, Rogers BE, Wuest F: Rerouting the metabolic pathway of 18F-labeled peptides: the influence of prosthetic groups. Bioconjug Chem 26:201-212, 2015. PMCID: None.
Richter S, Wuest M, Bergman CN, Krieger S, Rogers BE, Wuest F: Metabolically stabilized 68Ga-NOTA-Bombesin for PET imaging of prostate cancer and influence of protease inhibitor phosphoramidon. Mol Pharm 13:1347-1357, 2016. PMCID: None.
Rogers BE, Bigott HM, McCarthy DW, Della Manna D, Kim J, Sharp TL, Welch MJ: MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjug Chem 14:756-763, 2003. PMCID: None.
Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ: Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region. Cancer Biother Radiopharm 20:502-513, 2005. PMCID: None.
Sin, I.; Kang, C.; Bandara, N.; Sun, X; Zhong, Y.; Rogers, B. E; Chong, H.S., “Novel Hexadentate and Pentadentate Chelators for 64Cu-based Targeted PET Imaging”, Med. Chem. 2014, 22, 2553-2562.